ALung Technologies, Inc.

The Hemolung is a new therapy that replaces the respirator in the ICU, improves clinical outcomes and results in full payback with two weeks

  • Stage Concept Only
  • Industry Medical Devices and Equipment
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Employees 30
  • Website alung.com

Company Summary

Team

  • Peter DeComo
    Chairman & CEO

  • Nicholas Kuhn
    Chief Operating Officer

  • Peter DeComo

Advisors

  • Peter Blaiser, Reed Smith
    Lawyer
    Unconfirmed
    Mock, Bosco & Associates
    Accountant
    Unconfirmed

Previous Investors

  • Blue Tree, Innovation Works, Pittsburgh Life Sciences Greenhouse and private investors||
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free